Recombinant rabbit tissue factor based prothrombin time reagent

• US 6,100,072 A
• Filed: 04/22/1998
• Issued: 08/08/2000
• Est. Priority Date: 04/23/1997
• Status: Expired due to Term

• Current Assignee: Instrumentation Lab SPA (Instrumentation Lab)
• Original Assignee: Instrumentation Lab SPA (Instrumentation Lab)
• Inventors: Brucato, Cheryl, Bruguera, Pau, Sanchez-Martinez, Demetrio, Ruiz, Juan, Birr, Cynthia
• Primary Examiner(s): Carlson, Karen Cochrane
• Assistant Examiner(s): SCHNIZER, HOLLY G
• Application Number:
  US09/064,378
• Time in Patent Office: 839 Days
• Field of Search: 435/69.6, 435/69.7, 530/381, 530/415, 530/830
• US Class Current: 435/69.7
• CPC Class Codes: C07K 14/70596 Molecules with a "CD"-designation not provided for elsewhere
• CPC Class Codes: C07K 14/745 Blood coagulation or fibrinolysis factors
• CPC Class Codes: C12Q 1/56 involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
• CPC Class Codes: G01N 33/86 involving blood coagulating time or factors, or their receptors
• CPC Class Codes: Y10S 530/83 Plasma; serum

Abstract

Liquid and lyophilized reagents for determining prothrombin time and/or fibrinogen levels in a plasma sample are disclosed. The reagents preferably are based on recombinant rabbit tissue factor. Also disclosed is a purified preparation of recombinant rabbit tissue factor having unique properties, and a novel method for making PT reagents.

Claims

1. A method of preparing a liquid or a lyophilized reagent for determining prothrombin time or fibrinogen levels in a plasma sample, the method comprising the steps of:

(a) providing a solution, suspension or dispersion containing a phospholipid vesicle;

wherein said solution, suspension or dispersion is surfactant free;

(b) admixing surfactant solubilized tissue factor protein with said solution, suspension or dispersion; and

(c) incubating the mixture produced in step (b) under conditions and for a time sufficient to permit said surfactant-solubilized tissue factor protein to associate with said phospholipid vesicle to produce a reagent capable of inducing coagulation in the plasma sample without removal of the surfactant.

2. The method of claim 1, wherein the isolated tissue factor protein of step (b) is a recombinant rabbit tissue factor protein.

3. The method of claim 1 comprising the additional step of admixing the solution containing the protein-containing phospholipid vesicle of step (c) with a formulation buffer.

4. The method of claim 3, wherein the isolated tissue factor protein of step (b) is a recombinan rabbit tissue factor protein.

5. A purified preparation of recombinant rabbit tissue factor, said preparation comprising:

recombinant rabbit tissue factor comprising

an amino acid sequence defining from an N-terminus to a C-terminus,

(a) an extracellular domain,

(b) a lipid binding domain,

(c) an intracellular domain, and

(d) an affinity tag for use in selectively enriching said recombinant rabbit tissue factor;

wherein the purified preparation is enriched for the recombinant rabbit tissue factor protein having the lipid binding domain relative to a recombinant rabbit tissue factor without the affinity tag.

6. The purified preparation of claim 5, wherein the affinity tag comprises a plurality of consecutively linked histidine amino acids.

7. The purified preparation of claim 6, wherein the affinity tag comprises a (His)₆ sequence.

8. The purified preparation of claim 5, wherein the recombinant rabbit tissue factor reacts with Factor VII and Factor VIIa.

9. The purified preparation of claim 5, wherein the recombinant rabbit tissue factor can be used to produce a prothrombin time reagent having an ISI value of about 1.0.

10. The purified preparation of claim 5, wherein the recombinant rabbit tissue factor is less sensitive to PIVKAs in a plasma sample relative to human or bovine tissue factor.

11. A liquid or lyophilized reagent for determining prothrombin time or fibrinogen levels in a plasma sample, the reagent consisting essentially of:

(a) a surfactant-solubilized recombinant rabbit tissue factor protein;

(b) a phospholipid selected from the group consisting of phosphatidylcholine, phosphatidylserine, and a combination thereof; and

(c) a buffer system;

wherein the phospholipid contains a mixture of phosphatidylserine and phosphatidylcholine in a ratio from about 20;

80 to abut 30;

70.

12. The reagent of claim 11, wherein the protein to lipid ratio is from about 0.05 μ

g protein/mg phospholipid to about 30 μ

g protein/mg phospholipid.

13. The reagent of claim 12, wherein the protein to lipid ratio is from about 0.2 μ

g protein/mg phospholipid to about 20 μ

g protein/mg of phospholipid.

14. The reagent of claim 11, wherein the buffer system contains calcium ions in an amount sufficient for coagulation of the plasma sample.

15. The reagent of claim 11 or 14, wherein the buffer system has ionic strength sufficient to support coagulation in the plasma sample.

16. The reagent of claim 11 or 14, wherein the buffer system contains Hepes.

17. The reagent of claim 15, wherein the buffer system contains Hepes.

18. The reagent of claim 11, wherein the tissue factor protein comprises a purified preparation of recombinant rabbit tissue factor comprising:

an amino acid sequence defining from an N-terminus to a C-terminus,

(a) an extracellular domain,

(b) a lipid binding domain,

(c) an intracellular domain, and

(d) an affinity tag for use in selectively enriching said recombinant rabbit tissue factor,

wherein the purified preparation is enriched for the recombinant rabbit tissue factor protein having the lipid binding domain relative to a recombinant rabbit tissue factor without the affinity tag.

19. A method for measuring the amount of fibrinogen in a plasma sample, the method comprising the steps of:

(a) providing the plasma sample;

(b) providing the reagent of claim 11 or 18;

(c) mixing the reagent of step (b) with the plasma sample of step (a); and

(d) determining clot formation.